je.st
news
FDA approves Genentech drug for advanced lung cancer
2015-12-11 23:03:49| Biotech - Topix.net
The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain type of lung cancer who have few other options. Alecensa won accelerated approval for patients with advanced non-small cell lung cancer with a mutation in a gene called ALK who have relapsed after treatment with Pfizer Inc.'s Xalkori or who could not tolerate that drug.
Tags: advanced
drug
cancer
lung
Category:Biotechnology and Pharmaceuticals